If you’re interested in having breast augmentation, it’s not only the size and shape of the implants that you need to consider; it’s the brand too. And when it comes to a company with an unparalleled history of safety and efficacy, Motiva is a top pick. Its implants were first approved in 2010 and have been used in more than 85 countries across the globe since then; keep an eye out for the U.S. launch. Safety and women’s health have always been top priorities for the brand—so much so that they have their own Motiva Standard Campaign. Here, more on the three safety milestones that make up the Motiva Standard.
3 years of U.S. Motiva clinical data collected
The three-year update of the U.S. IDE study of Motiva Implants demonstrates the safety and effectiveness of these devices and is an addendum to the impressive data the brand has amassed over the past decade. Dr. Caroline Glicksman, a board-certified plastic surgeon in Sea Girt, New Jersey, and the first female medical director of a U.S. Food and Drug Administration (FDA) breast implant study, called out one particularly noteworthy point. She highlighted the consistency in clinical outcomes from year two to year three, with complication rates of less than 1% in both capsular contracture or suspected or confirmed rupture during this period. “These results are the latest evidence of the performance of Motiva implants, adding to data collected over 12 years and from more than 3 million implants placed in markets globally. We look forward to this new standard in breast implants being made available to women in the United States,” she said.
3 million implants in the market over the past 12+ years
Millions of women worldwide have experienced the Motiva difference. The latest Post-Market Surveillance Report provided by the company not only highlights the transparency of how the devices perform on a safety level but also further demonstrates the same low device-related complication as seen in the U.S. IDE clinical trial.
Less than 1% rate of device-related complications
Over the past decade, Motiva has let science, innovation, and medical evidence drive the creation of its implants, bringing new solutions and a new safety standard for women making critical choices around their breast health. This is demonstrated in more than 80 clinical publications, where device-related complications demonstrate a consistent rate of less than 1%.
